UPDATE: Goldman Sachs Upgrades Life Technologies to Neutral on Thermo Fisher Acquisition

Goldman Sachs analyst Isaac Ro published a report on Life Technologies (NASDAQ: LIFE ) that upgraded the stock from Sell to Neutral and raised the price target from $48.00 to $74.00. In the report, Goldman Sachs wrote, "We now see increased likelihood that LIFE will trade on M&A expectations and